These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25804482)

  • 1. Rationale for combining immunotherapy with chemotherapy.
    Dalgleish AG
    Immunotherapy; 2015; 7(3):309-16. PubMed ID: 25804482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.
    Naghavi AO; Johnstone PA; Kim S
    Curr Probl Cancer; 2016; 40(1):38-67. PubMed ID: 26656977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy.
    Sharabi AB; Lim M; DeWeese TL; Drake CG
    Lancet Oncol; 2015 Oct; 16(13):e498-509. PubMed ID: 26433823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy combined with immune checkpoint blockade immunotherapy: Achievements and challenges.
    Teng F; Kong L; Meng X; Yang J; Yu J
    Cancer Lett; 2015 Aug; 365(1):23-9. PubMed ID: 25980820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
    Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
    Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.
    Liu WM; Meyer B; Dalgleish AG
    J BUON; 2009 Sep; 14 Suppl 1():S103-9. PubMed ID: 19785052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
    Emens LA; Middleton G
    Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiotherapy and Immunotherapy: Improving Cancer Treatment through Synergy.
    Reynders K; De Ruysscher D
    Prog Tumor Res; 2015; 42():67-78. PubMed ID: 26383848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of cancer immunotherapy with clinically available drugs that can block immunosuppressive cells.
    Kim SJ; Ha GH; Kim SH; Kang CD
    Immunol Invest; 2014; 43(6):517-34. PubMed ID: 24295450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination approaches to immunotherapy: the radiotherapy example.
    Gough MJ; Crittenden MR
    Immunotherapy; 2009 Nov; 1(6):1025-37. PubMed ID: 20635917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.
    Serre R; Benzekry S; Padovani L; Meille C; André N; Ciccolini J; Barlesi F; Muracciole X; Barbolosi D
    Cancer Res; 2016 Sep; 76(17):4931-40. PubMed ID: 27302167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined chemoimmunotherapy of solid tumours: improving vaccines?
    Nowak AK; Lake RA; Robinson BW
    Adv Drug Deliv Rev; 2006 Oct; 58(8):975-90. PubMed ID: 17005292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future approaches in immunotherapy.
    Rini B
    Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of radiotherapy in the age of immunotherapy.
    Sato H; Demaria S; Ohno T
    Jpn J Clin Oncol; 2021 Apr; 51(4):513-522. PubMed ID: 33561212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immuno-oncology combinations: a review of clinical experience and future prospects.
    Antonia SJ; Larkin J; Ascierto PA
    Clin Cancer Res; 2014 Dec; 20(24):6258-68. PubMed ID: 25341541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressive networks and checkpoints controlling antitumor immunity and their blockade in the development of cancer immunotherapeutics and vaccines.
    Butt AQ; Mills KH
    Oncogene; 2014 Sep; 33(38):4623-31. PubMed ID: 24141774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy combined with chemotherapy in the treatment of tumors.
    Frazier JL; Han JE; Lim M; Olivi A
    Neurosurg Clin N Am; 2010 Jan; 21(1):187-94. PubMed ID: 19944977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation therapy and immunotherapy: implications for a combined cancer treatment.
    Levy A; Chargari C; Cheminant M; Simon N; Bourgier C; Deutsch E
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):278-87. PubMed ID: 23036459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing adoptive immunotherapy of cancer.
    Westwood JA; Berry LJ; Wang LX; Duong CP; Pegram HJ; Darcy PK; Kershaw MH
    Expert Opin Biol Ther; 2010 Apr; 10(4):531-45. PubMed ID: 20132063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.